Intronn Overview
- Founded
- 1988
- Status
- Acquired/Merged
- Employees
- 11
- Latest Deal Type
- M&A
- Financing Rounds
- 5
Intronn General Information
Description
Developer of spliceosome-mediated RNA trans-splicing (SMaRT) technology. The company has produced a series of PTMs capable of base-pairing to and trans-splicing with disease associated pre-mRNA targets.
Contact Information
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Virxsys
Primary Office
- 910 Clopper Road
- South Building, Suite 210
- Gaithersburg, MD 20878
- United States
+1 (240) 000-0000
Intronn Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Intronn‘s full profile, request access.
Request a free trialIntronn Patents
Intronn Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20040248141-A1 | Transgenic cell comprising nucleotide sequences which form triplex structures for use in diagnosis, prevention and treatment of skin, pigmentation and cell proliferative disorders | Abandoned | 17-Jul-2002 | 0000000000 | 0 |
| AU-2003256606-A1 | Spliceosome mediated rna trans-splicing for correction of skin disorders | Abandoned | 17-Jul-2002 | 0000000000 | |
| CA-2492469-A1 | Spliceosome mediated rna trans-splicing for correction of skin disorders | Abandoned | 17-Jul-2002 | 0000000000 | |
| US-20040018622-A1 | Therapy for skin disorders; genetic defects | Abandoned | 17-Jul-2002 | 0000000000 | 0 |
| JP-2005532815-A | Rna trans-splicing mediated by spliceosome for correction of skin diseases | Withdrawn | 17-Jul-2002 | C12N15/113 | 0 |
Intronn Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialIntronn Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Intronn‘s full profile, request access.
Request a free trial